Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof
The identification of tumor cell-specific surface markers is a key step towards personalized cancer medicine, allowing early assessment and accurate diagnosis, and development of efficacious targeted therapies. Despite significant efforts, currently the spectrum of cell membrane targets associated w...
Saved in:
Main Authors: | Sarah Shigdar (Author), Lisa Agnello (Author), Monica Fedele (Author), Simona Camorani (Author), Laura Cerchia (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamers and antibodies: rivals or allies in cancer targeted therapy?
by: Lisa Agnello, et al.
Published: (2021) -
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
by: Simona Camorani, et al.
Published: (2018) -
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles
by: Luis Exequiel Ibarra, et al.
Published: (2022) -
Aptamer-Based Diagnostics and Therapeutics
by: Sarah Shigdar
Published: (2019) -
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
by: Simona Camorani, et al.
Published: (2022)